We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
15 similar Transition and Succession Agreement contracts by Mylan Laboratories Inc, Mylan Inc., Mylan N.V.
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 10th, 2017 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 24th day of March, 2017, by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Daniel M. Gallagher (the “Executive”).
Standard Contracts
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 6th day of June, 2016, by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Kenneth S. Parks (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of January 10, 2006, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Harry A. Korman (“Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of February 25, 2008 (the “Commencement Date”) by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Anthony Mauro (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 30th, 2010 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 1st day of April, 2010 (this “Agreement”), by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and John Sheehan (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 26th, 2010 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of February 28_, 2008 (the “Commencement Date”) by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Daniel C. Rizzo, Jr. (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • August 3rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into on June 1, 2009, effective as of June 8, 2009 (the “Commencement Date”), by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Jolene Varney (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 12th, 2008 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into as of this 31st day of January, 2007 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Rajiv Malik (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 30th, 2007 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into as of this 31st day of January, 2007 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Rajiv Malik (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • January 10th, 2007 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into as of this 8th day of January, 2007 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Prasad Nimmagadda (the “Executive”).
AMENDED AND RESTATED TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 16th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AMENDED AND RESTATED TRANSITION AND SUCCESSION AGREEMENT, dated as of the 3rd day of April, 2006 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Stuart A. Williams (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AGREEMENT, dated as of the 15th day of December, 2003 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Louis J. DeBone (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AGREEMENT, dated as of the 15th day of December, 2003 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and John P. O’Donnell (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AGREEMENT, dated as of the 15th day of December, 2003 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Edward J. Borkowski (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of December 15, 2003, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and (“Executive”).